Evasion of Type I Interferon by SARS-CoV-2

Xia, Hongjie, Cao, Zengguo, Xie, Xuping, Zhang, Xianwen, Chen, John Yun-Chung, Wang, Hualei, Menachery, Vineet D., Rajsbaum, Ricardo +1 more·2020·Cell Reports
DOI 10.1016/j.celrep.2020.108234

Cited by (958)

Items 201–300 of 958

  1. NSP16 2′-O-MTase in Coronavirus Pathogenesis: Possible Prevention and Treatments Strategies
    Li‐Jen Chang, Tsung‐Hsien Chen · 2021 · Viruses
  2. Modeling recapitulates the heterogeneous outcomes of SARS-CoV-2 infection and quantifies the differences in the innate immune and CD8 T-cell responses between patients experiencing mild and severe symptoms
    Budhaditya Chatterjee, Harshbir Singh Sandhu, Narendra M. Dixit · 2022 · PLoS Pathogens
  3. Introduction of ORF3a-Q57H SARS-CoV-2 Variant Causing Fourth Epidemic Wave of COVID-19, Hong Kong, China
    Daniel K. W. Chu, Kenrie P. Y. Hui, Haogao Gu, Ronald LW Ko, Pavithra Krishnan, Daisy Y.M. Ng, Gigi Y.Z. Liu, Carrie K.C. Wan, Man-chun Cheung, Ka‐Chun Ng et al. · 2021 · Emerging infectious diseases
  4. SARS-CoV-2 variants: biology, pathogenicity, immunity and control
    Ryuta Uraki, Bette Korber, Michael Diamond, Yoshihiro Kawaoka · 2025 · Nature Reviews Microbiology
  5. Type-I interferon signatures in SARS-CoV-2 infected Huh7 cells
    Xi Chen, Elisa Saccon, K. Sofia Appelberg, Flora Mikaeloff, Jimmy Rodriguez Murillo, Beatriz Sá Vinhas, Teresa Frisan, Ákos Végvári, Alì Mirazimi, Ujjwal Neogi et al. · 2021 · Cell Death Discovery
  6. Tetherin antagonism by SARS‐CoV‐2 ORF3a and spike protein enhances virus release
    Hazel Stewart, Roberta Palmulli, Kristoffer H. Johansen, Naomi N. McGovern, Ola M. Shehata, George Carnell, Hannah K. Jackson, Jin S. Lee, Jonathan C. Brown, Thomas Burgoyne et al. · 2023 · EMBO Reports
  7. Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity
    J. Chaudhary, R. Yadav, P. Chaudhary, Anurag Maurya, Nimita Kant, O. Al Rugaie, H. Haokip, Deepika Yadav, Rakesh P. N. Roshan, R. Prasad et al. · 2021 · Cells
  8. Targeting SARS-CoV-2 Non-Structural Proteins
    W.G. Tam, Ana C. Lorenzo‐Leal, Luis Ricardo Hernández, Horacio Bach · 2023 · International Journal of Molecular Sciences
  9. Potential Applications of Conducting Polymers to Reduce Secondary Bacterial Infections among COVID-19 Patients: a Review
    Mohd Muzamir Mahat, Awis Sukarni Mohmad Sabere, Juzaili Azizi, Nur Asyura Nor Amdan · 2021 · Emergent Materials
  10. Of bats and men: Immunomodulatory treatment options for COVID-19 guided by the immunopathology of SARS-CoV-2 infection
    Michael J. Christie, Aaron Trent Irving, Samuel C. Forster, Benjamin J. Marsland, Philip M. Hansbro, Paul J. Hertzog, Claudia A. Nold‐Petry, Marcel F. Nold · 2021 · Science Immunology
  11. Woodsmoke particle exposure prior to SARS-CoV-2 infection alters antiviral response gene expression in human nasal epithelial cells in a sex-dependent manner
    Stephanie A. Brocke, Grant T. Billings, Sharon Taft-Benz, Neil E. Alexis, Mark T. Heise, Ilona Jaspers · 2022 · American Journal of Physiology-Lung Cellular and Molecular Physiology
  12. Versatile SARS-CoV-2 Reverse-Genetics Systems for the Study of Antiviral Resistance and Replication
    Ulrik Fahnøe, Long V. Pham, Carlota Fernandez-Antunez, Rui Costa, Lizandro René Rivera-Rangel, Andrea Galli, Shan Feng, Lotte S. Mikkelsen, Judith M. Gottwein, Troels K. H. Scheel et al. · 2022 · Viruses
  13. Janus Kinase Signaling Pathway and Its Role in COVID-19 Inflammatory, Vascular, and Thrombotic Manifestations
    Jonathan D. Ravid, Orly Leiva, Vipul Chimanlal Chitalia · 2022 · Cells
  14. The RNA helicase DHX16 recognizes specific viral RNA to trigger RIG-I-dependent innate antiviral immunity
    Adam Hage, Preeti Bharaj, Sarah van Tol, María I. Giraldo, María González-Orozco, Karl M. Valerdi, Abbey N. Warren, Leopoldo Aguilera-Aguirre, Xuping Xie, Steven G. Widen et al. · 2022 · Cell Reports
  15. Marine Natural Products as Leads against SARS-CoV-2 Infection
    Bhuwan Khatri Chhetri, Philip R. Tedbury, Anne Marie Sweeney-Jones, Luke Mani, Katy Soapi, Candela Manfredi, Eric J. Sorscher, Stefan G. Sarafianos, Julia Kubanek · 2022 · Journal of Natural Products
  16. Structural Analysis of SARS-CoV-2 ORF8 Protein: Pathogenic and Therapeutic Implications
    Antonio Valcarcel, Antonio Bensussen, Elena R Alvarez-Buylla, José Dı́az · 2021 · Frontiers in Genetics
  17. Evaluating the Virology and Evolution of Seasonal Human Coronaviruses Associated with the Common Cold in the COVID-19 Era
    Cameron M. Harrison, Jayden M. Doster, Emily H. Landwehr, Nidhi P. Kumar, Ethan J. White, Dia C. Beachboard, Christopher C. Stobart · 2023 · Microorganisms
  18. Reduced replication but increased interferon resistance of SARS-CoV-2 Omicron BA.1
    Rayhane Nchioua, Annika Schundner, Susanne Klute, Lennart Koepke, Maximilian Hirschenberger, Sabrina Noettger, Giorgio Fois, Fabian Zech, Alexander Graf, Stefan Krebs et al. · 2023 · Life Science Alliance
  19. New insights into the pathogenesis of SARS-CoV-2 during and after the COVID-19 pandemic
    Jonatan J. Carvajal, Valeria García-Castillo, Shelsy V. Cuellar, Claudia P. Campillay-Véliz, Camila Salazar‐Ardiles, Andrea M. Avellaneda, Christian A. Muñoz, Angello R Retamal-Díaz, Susan M. Bueno, Pablo A. González et al. · 2024 · Frontiers in Immunology
  20. Human Kidney Spheroids and Monolayers Provide Insights into SARS-CoV-2 Renal Interactions
    Dorit Omer, Oren Pleniceanu, Yehudit Gnatek, Michael Namestnikov, Osnat Cohen-Zontag, Sanja Goldberg, Yehudit Eden-Friedman, Nehemya Friedman, Michal Mandelboim, Einat B. Vitner et al. · 2021 · Journal of the American Society of Nephrology
  21. Dexamethasone for Severe COVID-19: How Does It Work at Cellular and Molecular Levels?
    Tomoshige Kino, Irina D. Burd, James H. Segars · 2021 · International Journal of Molecular Sciences
  22. The Translational Landscape of SARS-CoV-2-infected Cells Reveals Suppression of Innate Immune Genes
    Maritza Puray‐Chavez, Nakyung Lee, Kasyap Tenneti, Yiqing Wang, Hung R. Vuong, Yating Liu, Amjad Horani, Tao Huang, Sean P. Gunsten, James Brett Case et al. · 2022 · mBio
  23. Revealing the mystery of persistent smell loss in long COVID patients
    Jung Woo Park, Xiaoyan Wang, Ren‐He Xu · 2022 · International Journal of Biological Sciences
  24. Impairment of antiviral immune response and disruption of cellular functions by SARS-CoV-2 ORF7a and ORF7b
    Tránsito García‐García, Raúl Fernández‐Rodríguez, Natalia Redondo, Ana de Lucas‐Rius, Sara Zaldívar‐López, Blanca Dies López-Ayllón, José M. Suárez-Cárdenas, Ángeles Jiménez-Marín, María Montoya, Juan J. Garrido · 2022 · iScience
  25. SARS‐CoV‐2 NSP7 inhibits type I and III IFN production by targeting the RIG‐I/MDA5, TRIF, and STING signaling pathways
    Jian Deng, Yi Zheng, Shengnan Zheng, Mei‐Ling Nan, Lulu Han, Jing Zhang, Yunyun Jin, Ji‐An Pan, Chengjiang Gao, Pei‐Hui Wang · 2023 · Journal of Medical Virology
  26. Understanding Individual SARS-CoV-2 Proteins for Targeted Drug Development against COVID-19
    Joyce van de Leemput, Zhe Han · 2021 · Molecular and Cellular Biology
  27. The emergence and ongoing convergent evolution of the N501Y lineages coincides with a major global shift in the SARS-CoV-2 selective landscape
    Darren P Martin, Steven Weaver, Houryiah Tegally, Emmanuel James San, Stephen D. Shank, Eduan Wilkinson, Alexander G. Lucaci, Jennifer Giandhari, Sureshnee Naidoo, Yeshnee Pillay et al. · 2021 · PubMed
  28. COVID-19 and the Immune Response: A Multi-Phasic Approach to the Treatment of COVID-19
    Tzuriel Sapir, Zaelig Averch, Brian Lerman, Abraham Bodzin, Yeshaya Fishman, Radhashree Maitra · 2022 · International Journal of Molecular Sciences
  29. Modulation of innate immunity in airway epithelium for host-directed therapy
    Iwona T. Myszor, Gudmundur Hrafn Gudmundsson · 2023 · Frontiers in Immunology
  30. Interferon antagonists encoded by SARS-CoV-2 at a glance
    Jung‐Hyun Lee, Lennart Koepke, Frank Kirchhoff, Konstantin M. J. Sparrer · 2022 · Medical Microbiology and Immunology
  31. Retinol Depletion in COVID-19
    Aziz Rodan Sarohan, Hakan Akelma, Eşref Araç, Özgür Aslan, Osman Çen · 2022 · Clinical Nutrition Open Science
  32. Characterization and structural basis of a lethal mouse-adapted SARS-CoV-2
    Shihui Sun, Hongjing Gu, Lei Cao, Qi Chen, Qing Ye, Guan Yang, Rui-Ting Li, Hang Fan, Yong‐Qiang Deng, Xiaopeng Song et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  33. A PCR amplicon-based SARS-CoV-2 replicon for antiviral evaluation
    Tomohiro Kotaki, Xuping Xie, Pei‐Yong Shi, Masanori Kameoka · 2021 · Scientific Reports
  34. The Role of Viral RNA Degrading Factors in Shutoff of Host Gene Expression
    Léa Gaucherand, Marta Maria Gaglia · 2022 · Annual Review of Virology
  35. Cytokines and microRNAs in SARS-CoV-2: What do we know?
    Fahimeh Zamani Rarani, Bahman Rashidi, Mohammad Hassan Jafari Najaf Abadi, Michael Richard Hamblin, Seyed Mohammad Reza Hashemian, Hamed Mirzaei · 2022 · Molecular Therapy — Nucleic Acids
  36. Anti-MDA5 Antibody Linking COVID-19, Type I Interferon, and Autoimmunity: A Case Report and Systematic Literature Review
    Antonio Tonutti, Francesca Motta, Angela Ceribelli, Natasa Isailovic, Carlo Francesco Selmi, Maria De Santis · 2022 · Frontiers in Immunology
  37. Reverse genetic systems of SARS-CoV-2 for antiviral research
    Chaitanya Kurhade, Xuping Xie, Pei‐Yong Shi · 2022 · Antiviral Research
  38. Systematic functional interrogation of SARS-CoV-2 host factors using Perturb-seq
    Sara Sunshine, Andreas S. Puschnik, Joseph M. Replogle, Matthew T. Laurie, Jamin Liu, Beth Shoshana Zha, James K. Nuñez, Janie Rae Byrum, Aidan H. McMorrow, Matthew B. Frieman et al. · 2023 · Nature Communications
  39. Immune correlates of protection for SARS-CoV-2, Ebola and Nipah virus infection
    Beatriz Escudero-Pérez, Philip Lawrence, Javier Castillo‐Olivares · 2023 · Frontiers in Immunology
  40. Promising Therapy for Heart Failure in Patients with Severe COVID-19: Calming the Cytokine Storm
    Xiang Peng, Yani Wang, Xiangwen Xi, Ying Jia, Jiangtian Tian, Bo Yu, Jinwei Tian · 2021 · Cardiovascular Drugs and Therapy
  41. “Post Coronavirus Disease (COVID-19) Reactivation of a Quiescent Unilateral Anterior Uveitis”
    Srinivasan Sanjay, Deepashri Mutalik, Sunil Gowda, Padmamalini Mahendradas, Ankush Kawali, Rohit Shetty · 2021 · SN Comprehensive Clinical Medicine
  42. SARS-CoV-2 ORF8: A Rapidly Evolving Immune and Viral Modulator in COVID-19
    Ariana Arduini, Frederique Laprise, Chen Liang · 2023 · Viruses
  43. Mutations in SARS-CoV-2 variant nsp6 enhance type-I interferon antagonism
    Cody J. Bills, Hongjie Xia, John Yun-Chung Chen, Jason Yeung, Birte Kalveram, David Hughes Walker, Xuping Xie, Pei‐Yong Shi · 2023 · Emerging Microbes & Infections
  44. Role of interferons in the antiviral battle: from virus-host crosstalk to prophylactic and therapeutic potential in SARS-CoV-2 infection
    Grigore Mihăescu, Mariana Carmen Chifiriuc, Roxana Filip, Coralia Bleoţu, Lia-Mara Diţu, Marian Constantin, Roxana-Elena Cristian, Raluca Grigore, Serban Vifor Bertesteanu, Gloria Simona Berteșteanu et al. · 2024 · Frontiers in Immunology
  45. Mutational dynamics of SARS-CoV-2: Impact on future COVID-19 vaccine strategies
    Niloofar Faraji, Tahereh Zeinali, Farahnaz Joukar, Maryam Sadat Aleali, Narges Eslami, Mohammad Shenagari, Fariborz Mansour‐Ghanaei · 2024 · Heliyon
  46. An intranasal nanoparticle STING agonist protects against respiratory viruses in animal models
    Ankita Leekha, Arash Saeedi, Monish Kumar, K M Samiur Rahman Sefat, Melisa A. Martinez-Paniagua, Hui Meng, Mohsen Fathi, Rohan SUDHIR Kulkarni, Kate Reichel, Sujit Biswas et al. · 2024 · Nature Communications
  47. Inferring effects of mutations on SARS-CoV-2 transmission from genomic surveillance data
    Brian Lee, Ahmed Abdul Quadeer, Muhammad Saqib Sohail, Elizabeth Finney, Syed Faraz Ahmed, Matthew R. McKay, John P. Barton · 2025 · Nature Communications
  48. Why Do Some People Develop Serious COVID-19 Disease After Infection, While Others Only Exhibit Mild Symptoms?
    Mark C. Ballow, Christopher L. Haga · 2021 · The Journal of Allergy and Clinical Immunology In Practice
  49. How SARS-CoV-2 and Other Viruses Build an Invasion Route to Hijack the Host Nucleocytoplasmic Trafficking System
    Elma Sakinatus Sajidah, Keesiang Lim, Richard Wing-Chuen Wong · 2021 · Cells
  50. SARS-CoV-2 Spike protein enhances ACE2 expression via facilitating Interferon effects in bronchial epithelium
    Ye Zhou, Mu Wang, Yunhui Li, Pei‐Hui Wang, Ping Zhao, Zixuan Yang, Suyuan Wang, Liyuan Zhang, Zhenyang Li, Kaiwei Jia et al. · 2021 · Immunology Letters
  51. Cytokine storm in the pathophysiology of COVID-19: Possible functional disturbances of miRNAs
    Mona Aslani, Seyed Shahabeddin Mortazavi‐Jahromi, Abbas Mirshafiey · 2021 · International Immunopharmacology
  52. Structural basis for the interaction of SARS‐CoV ‐2 virulence factor nsp1 with DNA polymerase α–primase
    Mairi Louise Kilkenny, Charlotte E. Veale, Amir Guppy, Steven W. Hardwick, Dimitri Y. Chirgadze, Neil J. Rzechorzek, Joseph D Maman, Luca Pellegrini · 2021 · Protein Science
  53. Human Nasal Epithelial Cells Sustain Persistent SARS-CoV-2 Infection In Vitro , despite Eliciting a Prolonged Antiviral Response
    Akshamal Mihiranga Gamage, Kai Sen Tan, Wharton O. Y. Chan, Zhe Zhang Ryan Lew, Jing Liu, Chee Wah Tan, Deepa Rajagopalan, Quy Xiao Xuan Lin, Le Min Tan, Prasanna Nori Venkatesh et al. · 2022 · mBio
  54. RIG-I-induced innate antiviral immunity protects mice from lethal SARS-CoV-2 infection
    Samira Marx, Beate Mareike Kümmerer, Christian Grützner, Hiroki Kato, Martin Schlee, Marcel Renn, Eva Bartok, Gunther Hartmann · 2022 · Molecular Therapy — Nucleic Acids
  55. Human coronaviruses disassemble processing bodies
    Mariel Kleer, Rory P. Mulloy, Carolyn-Ann Robinson, Danyel Evseev, Maxwell P. Bui-Marinos, Elizabeth L. Castle, Arinjay Banerjee, Samira Mubareka, Karen Louise Mossman, Jennifer A. Corcoran · 2022 · PLoS Pathogens
  56. Structural and functional characterization of NEMO cleavage by SARS-CoV-2 3CLpro
    Mikhail A. Hameedi, Erica Teixeira Prates, Michael R. Garvin, Irimpan I. Mathews, B Kirtley Amos, Omar Demerdash, Mark Bechthold, Mamta Iyer, Simin Rahighi, Daniel W. Kneller et al. · 2022 · Nature Communications
  57. Aptamers for Detection and Diagnostics (ADD): Can mobile systems process optical data from aptamer sensors to identify molecules indicating presence of SARS-CoV-2 virus? Should healthcare explore aptamers as drugs for prevention as well as its use as adjuvants with antibodies and vaccines?
    Shoumen Datta · 2020 · ChemRxiv
  58. Ribosome-Profiling Reveals Restricted Post Transcriptional Expression of Antiviral Cytokines and Transcription Factors during SARS-CoV-2 Infection
    Marina R. Alexander, Aaron M. Brice, Petrus Jansen van Vuren, Christina L. Rootes, Leon Tribolet, Christopher J. Cowled, Andrew G. D. Bean, Cameron R. Stewart · 2021 · International Journal of Molecular Sciences
  59. Study of HLA-A, -B, -C, -DRB1 and -DQB1 polymorphisms in COVID-19 patients
    Juan Francisco Gutiérrez‐Bautista, Antonio Rodríguez-Nicolás, Antonio Rosales‐Castillo, Miguel Ángel López‐Ruz, Antonia María Martín-Casares, Alonso Fernández-Rubiales, Per O. Anderson, Federico Garrido, Francisco Ruiz‐Cabello, Miguel Ángel López‐Nevot · 2021 · Journal of Microbiology Immunology and Infection
  60. Cellular and Molecular Effects of SARS-CoV-2 Linking Lung Infection to the Brain
    Linda Francistiová, Adrián Klepe, Géza Curley, Károly Gulya, András Dinnyés, Kata Filkor · 2021 · Frontiers in Immunology
  61. Pathogenic and transcriptomic differences of emerging SARS-CoV-2 variants in the Syrian golden hamster model
    Kyle Lee O’Donnell, Amanda N. Pinski, Chad S. Clancy, Tylisha Gourdine, Kyle Shifflett, Paige Fletcher, Ilhem Messaoudi, Andrea Marzi · 2021 · EBioMedicine
  62. The importance of accessory protein variants in the pathogenicity of SARS-CoV-2
    Sk. Sarif Hassan, Pabitra Pal Choudhury, Guy W. Dayhoff, Alaa A. A. Aljabali, Bruce D. Uhal, Kenneth H. Lundstrom, Nima Rezaei, Damiano Pizzol, Parise Adadi, Amos Lal et al. · 2022 · Archives of Biochemistry and Biophysics
  63. Airway epithelial interferon response to SARS-CoV-2 is inferior to rhinovirus and heterologous rhinovirus infection suppresses SARS-CoV-2 replication
    Elizabeth R. Vanderwall, Kaitlyn A. Barrow, Lucille M. Rich, David Fraser Read, Cole Trapnell, Oghenemega Okoloko, Steven F. Ziegler, Teal S. Hallstrand, Maria P. White, Jason S. Debley · 2022 · Scientific Reports
  64. Evolution of SARS-CoV-2 in Spain during the First Two Years of the Pandemic: Circulating Variants, Amino Acid Conservation, and Genetic Variability in Structural, Non-Structural, and Accessory Proteins
    Paloma Troyano-Hernáez, Roberto Reinosa, África Holguín · 2022 · International Journal of Molecular Sciences
  65. The main protease of SARS-CoV-2 cleaves histone deacetylases and DCP1A, attenuating the immune defense of the interferon-stimulated genes
    Liu Song, Dianbing Wang, Ghulam Abbas, Min Li, Mengmeng Cui, Jufang Wang, Zhanglin Lin, Xian‐En Zhang · 2023 · Journal of Biological Chemistry
  66. The NSP4 T492I mutation increases SARS-CoV-2 infectivity by altering non-structural protein cleavage
    Xiaoyuan Lin, Zhou Sha, Jakob Trimpert, Dušan Kunec, Chen Jiang, Yan Xiong, Binbin Xu, Zhenglin Zhu, Weiwei Xue, Haibo Wu · 2023 · Cell Host & Microbe
  67. The Coronavirus helicase in replication
    Samantha L. Grimes, Mark R. Denison · 2024 · Virus Research
  68. Interferon-Lambda Intranasal Protection and Differential Sex Pathology in a Murine Model of SARS-CoV-2 Infection
    Sook-Young Sohn, J. Hearing, J. Mugavero, V. Kirillov, E. Gorbunova, Luke Helminiak, S. Mishra, E. Mackow, P. Hearing, N. Reich et al. · 2021 · mBio
  69. Pyronaridine Protects against SARS-CoV-2 Infection in Mouse
    Ana C. Puhl, Giovanni Freitas Gomes, Samara Damasceno, Andre Schutzer Godoy, G.D. Noske, Aline Minalli Nakamura, Victor Oliveira Gawriljuk, R.S. Fernandes, Natalia Monakhova, Olga Riabova et al. · 2022 · ACS Infectious Diseases
  70. Herpes Simplex Virus 1 (HSV-1) Reactivation in Critically Ill COVID-19 Patients: A Brief Narrative Review
    Daniele Roberto Giacobbe, Stefano Di Bella, Antonio Lovecchio, Lorenzo Ball, Andrea De Maria, Antonio Vena, Bianca Marisa Bruzzone, Giancarlo Icardi, Paolo P. Pelosi, Roberto Luzzati et al. · 2022 · Infectious Diseases and Therapy
  71. Recent advances in applying G-quadruplex for SARS-CoV-2 targeting and diagnosis: A review
    Li-Yan Zhai, Ai-Min Su, Jing-Fan Liu, Jian-Jin Zhao, Xu‐Guang Xi, Xi‐Miao Hou · 2022 · International Journal of Biological Macromolecules
  72. SARS-CoV-2 ORF8 Protein Induces Endoplasmic Reticulum Stress-like Responses and Facilitates Virus Replication by Triggering Calnexin: an Unbiased Study
    Xuefeng Wang, Wenqi Wang, Tiecheng Wang, Jianzhong Wang, Yuhang Jiang, Xue Wang, Ze Qiu, Na Feng, Weiyang Sun, Chang Li et al. · 2023 · Journal of Virology
  73. A safe, effective and adaptable live-attenuated SARS-CoV-2 vaccine to reduce disease and transmission using one-to-stop genome modifications
    Jacob Schön, G. Tuba Barut, Bettina Salome Trüeb, Nico Joël Halwe, Inês Berenguer Veiga, Annika Kratzel, Lorenz Ulrich, Jenna Nicole Kelly, Melanie Brügger, Claudia Wylezich et al. · 2024 · Nature Microbiology
  74. ISGylation of the SARS-CoV-2 N protein by HERC5 impedes N oligomerization and thereby viral RNA synthesis
    Junji Zhu, Guanqun Liu, Zuberwasim Sayyad, Christopher M. Goins, Shaun R. Stauffer, Michaela U. Gack · 2024 · Journal of Virology
  75. SARS–CoV-2 Immuno-Pathogenesis and Potential for Diverse Vaccines and Therapies: Opportunities and Challenges
    Andrew R. McGill, Roukiah Khalil, Rinku Dutta, Ryan J. Green, Mark Howell, Subhra Mohapatra, Shyam S. Mohapatra · 2021 · Infectious Disease Reports
  76. SARS-CoV-2 NSP12 Protein Is Not an Interferon-β Antagonist
    Aixin Li, Kaitao Zhao, Bei Zhang, Rong-Hong Hua, Yujie Fang, Wuhui Jiang, Jing Zhang, Lixia Hui, Yingcheng Zheng, Yan Li et al. · 2021 · Journal of Virology
  77. DIA-Based Proteome Profiling of Nasopharyngeal Swabs from COVID-19 Patients
    Dong‐Gi Mun, Patrick M. Vanderboom, Anil Kumar Madugundu, Kishore Garapati, Sandip Chavan, Jane A. Peterson, Mayank Saraswat, Akhilesh Pandey · 2021 · Journal of Proteome Research
  78. Long-Read RNA Sequencing Identifies Polyadenylation Elongation and Differential Transcript Usage of Host Transcripts During SARS-CoV-2 In Vitro Infection
    Jessie J.‐Y. Chang, Josie Gleeson, Daniel Rawlinson, Miranda E. Pitt, Ricardo De Paoli‐Iseppi, Chenxi Zhou, Francesca L. Mordant, Sarah L. Londrigan, Michael B. Clark, Kanta Subbarao et al. · 2022 · Frontiers in Immunology
  79. Innate Immune Response and Inflammasome Activation During SARS-CoV-2 Infection
    Mohammad Islamuddin, Salman Ahmad Mustfa, Shehla Nasar Mir Najib Ullah, Usmaan Omer, Kentaro Kato, Shama Parveen · 2022 · Inflammation
  80. SARS-CoV-2 Variant Delta Potently Suppresses Innate Immune Response and Evades Interferon-Activated Antiviral Responses in Human Colon Epithelial Cells
    Dixit Tandel, Vishal Sah, Nitesh Kumar Singh, Poojitha Sai Potharaju, Divya Gupta, S. Shrivastava, D. T. Sowpati, K. H. Harshan · 2022 · Microbiology spectrum
  81. Immune Response to Viruses
    Jenny Amanda Herbert, Stavros Panagiotou · 2022 · Elsevier eBooks
  82. SARS-CoV-2 Nsp15 suppresses type I interferon production by inhibiting IRF3 phosphorylation and nuclear translocation
    Dianqi Zhang, Likai Ji, Xu Chen, HE Yu-min, Yijie Sun, Ji Li, Tiancheng Zhang, Quan Shen, Xiaochun Wang, Yan Wang et al. · 2023 · iScience
  83. Predicted coronavirus Nsp5 protease cleavage sites in the human proteome
    Benjamin M. Scott, Vincent Lacasse, Ditte G. Blom, Peter D. Tonner, Nikolaj Blom · 2022 · BMC Genomic Data
  84. Viral E protein neutralizes BET protein-mediated post-entry antagonism of SARS-CoV-2
    Irene P. Chen, James E. Longbotham, Sarah McMahon, Rahul K. Suryawanshi, Mir Mubashir Khalid, Taha Y. Taha, Takako Tabata, Jennifer M. Hayashi, Frank W. Soveg, Jared Carlson-Stevermer et al. · 2022 · Cell Reports
  85. The SARS-CoV-2 protein ORF3c is a mitochondrial modulator of innate immunity
    Hazel Stewart, Yongxu Lu, Sarah M. O’Keefe, Anusha Valpadashi, Luis Daniel Cruz‐Zaragoza, Hendrik A. Michel, Samantha K. Nguyen, George Carnell, Nina I. Lukhovitskaya, Rachel Milligan et al. · 2023 · iScience
  86. Inhibition of mRNA nuclear export promotes SARS-CoV-2 pathogenesis
    Menghan Mei, Anastasija Čupić, Lisa Miorin, Chengjin Ye, Tolga Çağatay, Ke Zhang, Komal Patel, Natalie Wilson, William Hayes McDonald, Nicholas A. Crossland et al. · 2024 · Proceedings of the National Academy of Sciences
  87. Comparison of the Characteristics of Cytokine Storm and Immune Response Induced by SARS-CoV, MERS-CoV, and SARS-CoV-2 Infections
    Tong Liu, Meng Feng, Zexin Wen, Yijie He, Wei Lin, Min Zhang · 2021 · Journal of Inflammation Research
  88. The effect of vitamin D, magnesium and zinc supplements on interferon signaling pathways and their relationship to control SARS-CoV-2 infection
    Mohsen Nabi‐Afjadi, Hadis Karami, Kaveh Goudarzi, Iraj Alipourfard, Elham Bahreini · 2021 · Clinical and Molecular Allergy
  89. SARS-CoV-2-Encoded MiRNAs Inhibit Host Type I Interferon Pathway and Mediate Allelic Differential Expression of Susceptible Gene
    Youwei Zhu, Zhaoyang Zhang, Jia Tao Song, Weizhou Qian, Gu Xiangqian, Chaoyong James Yang, Nan Shen, Feng Xue, Yuanjia Tang · 2021 · Frontiers in Immunology
  90. Non-invasive administration of AAV to target lung parenchymal cells and develop SARS-CoV-2-susceptible mice
    Myeon‐Sik Yang, Min-Jung Park, Junhyeong Lee, Byungkwan Oh, Kyung Won Kang, Yeon‐Hwa Kim, Sang‐Myeong Lee, Je‐Oh Lim, Tae-Yang Jung, Jong‐Hwan Park et al. · 2022 · Molecular Therapy
  91. High diversity in Delta variant across countries revealed by genome‐wide analysis of SARS‐CoV‐2 beyond the Spike protein
    Rohit Suratekar, Pritha Ghosh, Michiel J.M. Niesen, Gregory Donadio, Praveen Anand, Venky Soundararajan, AJ Venkatakrishnan · 2022 · Molecular Systems Biology
  92. Stable Cell Clones Harboring Self-Replicating SARS-CoV-2 RNAs for Drug Screen
    Shufeng Liu, Chao‐Kai Chou, Wells W. Wu, Binquan Luan, Tony T. Wang · 2022 · Journal of Virology
  93. High Expression of HERV-K (HML-2) Might Stimulate Interferon in COVID-19 Patients
    Yaolin Guo, Caiqin Yang, Yongjian Liu, Tianyi Li, Hanping Li, Jingwan Han, Lei Jia, Xiaolin Wang, Bohan Zhang, Jingyun Li et al. · 2022 · Viruses
  94. SARS‐CoV‐2 modulation of RIG‐I‐MAVS signaling: Potential mechanisms of impairment on host antiviral immunity and therapeutic approaches
    Mingming Wang, Yue Zhao, Juan Liu, Ting Li · 2022 · MedComm – Future Medicine
  95. SARS-CoV-2 and the host-immune response
    David P. Maison, Youping Deng, Mariana Gerschenson · 2023 · Frontiers in Immunology
  96. Construction of Non-infectious SARS-CoV-2 Replicons and Their Application in Drug Evaluation
    Bei Wang, Chongyang Zhang, Xiaobo Lei, Lili Ren, Zhendong Zhao, Jianwei Wang, He Huang · 2021 · Virologica Sinica
  97. SARS-CoV-2 Infection: Host Response, Immunity, and Therapeutic Targets
    Pooja Shivshankar, Harry Karmouty‐Quintana, Tingting Mills, Marie–Françoise Doursout, Yanyu Wang, Agnieszka K. Czopik, Scott E. Evans, Holger K. Eltzschig, Xiaoyi Yuan · 2022 · Inflammation
  98. The multiple roles of nsp6 in the molecular pathogenesis of SARS-CoV-2
    Cody J. Bills, Xuping Xie, Pei‐Yong Shi · 2023 · Antiviral Research
  99. Reverse genetics systems for SARS-CoV-2: Development and applications
    Hou-Li Cai, Yao‐Wei Huang · 2023 · Virologica Sinica
  100. Type I and III IFN-mediated antiviral actions counteracted by SARS-CoV-2 proteins and host inherited factors
    Jorge Fabián Quarleri, M. Victoria Delpino · 2021 · Cytokine & Growth Factor Reviews